Toceranib phosphate (Palladia) reverses type 1 diabetes by preserving islet function in mice

In recent years, strategies targeting β-cell protection via autoimmune regulation have been suggested as novel and potent immunotherapeutic interventions against type 1 diabetes mellitus (T1D). Here, we investigated the potential of toceranib (TOC), a receptor-type tyrosine kinase (RTK) inhibitor us...

Descripción completa

Detalles Bibliográficos
Autores principales: KISHI, Kazuhisa, YONEZAWA, Tomohiro, KAJI, Noriyuki, GOTO, Momo, NONOSHITA, Yuma, IIO, Aki, TSURU, Yoshiharu, HORI, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372262/
https://www.ncbi.nlm.nih.gov/pubmed/37258127
http://dx.doi.org/10.1292/jvms.23-0154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372262/
https://www.ncbi.nlm.nih.gov/pubmed/37258127
http://dx.doi.org/10.1292/jvms.23-0154

Ejemplares similares